Martin-Macintosh EL, Broski SM, Johnson GB, Hunt CH, Cullen EL, Peller PJ
Molecular and cellular bases of lipodystrophy syndromes
Tobacco Use Disorder Outcomes Wang, Volkow, and colleagues also conducted a study of 222,942 individuals with tobacco use disorder and type 2 diabetes, with findings showing individuals prescribed semaglutide showed a 32% lower risk of tobacco-related healthcare visits and were less likely to need smoking cessation medications or counseling during the 12-month follow-up period, with the most notable effects appearing within the first 30 days (Wang et al., 2024c)
New, severe or persistent symptoms should be reviewed by a healthcare provider rather than assumed to be caused by food or hydration alone
We note that the individual payments, and therefore copayments, associated with services may differ based on the setting in which they are furnished